Related Experiment Video
Updated: Mar 19, 2026

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
Sweat Gland Carcinoma With Neuroendocrine Differentiation (SCAND) Harboring a Novel GATA3 Frameshift Extension
Myles R McCrary1, Pei-Ling Chen2, Jane L Messina2
1Department of Pathology and Cell Biology, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA.
A rare aggressive sweat-gland carcinoma with neuroendocrine differentiation (SCAND) was identified in an elderly male. Molecular analysis revealed a novel GATA3 mutation, supporting SCAND as a distinct entity with a poor prognosis.
Area of Science:
- Dermatopathology
- Oncology
- Molecular Pathology
Background:
- Sweat-gland carcinoma with neuroendocrine differentiation (SCAND) is a rare and aggressive cutaneous adnexal tumor.
- Metastatic presentations of SCAND are infrequently reported, posing diagnostic challenges.
More Related Videos
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023